NLS Cancer

Immunotherapy is the 2016 Clinical Cancer Advance of the Year and a promising new strategy for treating cancer. But how far have we come? The American Society of Clinical Oncology (ASCO) justified this year’s choice of Clinical Cancer Advance, immunotherapy, by the fact that no recent advance has been more transformative, particularly over this past […]

Symphogen, a biopharmaceutical company developing recombinant antibody mixtures, published two papers with new clinical data for its lead anti-EGFR antibody mixture, Sym004, in the journals Cancer Discovery and in Cancer Chemotherapy and Pharmacology. In addition, a paper in Clinical Cancer Research described preclinical findings relating to the company’s pan-HER product candidate, Sym013, a mixture of six antibodies targeting each of […]

Swedish medical researchers have discovered a method for distinguishing between the most serious pediatric cancer cases and those that are less aggressive. About 20 percent of  Swedish and Norwegian children diagnosed with cancer die of the disease. Oncologists have found  it difficult to predict which children will improve and which will suffer a recurrence after treatment. The researchers from Sweden’s Lund […]

Genmab A/S announced it has reached a milestone in its DuoBody technology platform collaboration with Janssen Biotech, Inc., triggering a $3 million payment.  The milestone payment is for pre-clinical progress with a DuoBody product candidate targeting cancer. “This milestone marks further progress in our DuoBody collaboration with Janssen.  There are now 10 bispecific antibody programs […]

Researchers from the University of Copenhagen have demonstrated that selenium – naturally found in garlic and broccoli – slows down the body’s over-response to certain cancers that leaves patients feeling weak. The findings, which could improve cancer treatment, have been published in the Journal of Biological Chemistry. Cells undergoing change, such as precursors of cancer […]

Scientists at Denmark’s University of Copenhagen Biotic Research and Innovation Centre are trying to find a way to deactivate cells called fibroblasts, which can allow a malignant tumor to change and spread throughout the body. So far scientists have been able to observe how, and under which conditions, cancer cells activate fibroblasts. Finding out how […]